title: Bevicizumab and thrombosis: some answers but questions remain.
authors.affiliation: Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, Oregon.
authors.forename: Thomas G
authors.initials: TG
authors.lastname: DeLoughery
authors.forename: Tomasz M
authors.initials: TM
authors.lastname: Beer
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001158:Arteries / Q000473:pathology*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D013923:Thromboembolism / Q000209:etiology*; D054556:Venous Thromboembolism / Q000209:etiology*